Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
• To evaluate the safety,tolerability and pharmacokinetics of single intravenous doses of WCK
5107 alone and in combination with cefepime in healthy adult human subjects.